Systems Pharmacology
Cross-source consensus on Systems Pharmacology from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Comparisons
Background
Evidence quality
Highlighted claims
- Systems pharmacology rejects single-target approaches as scientifically implausible because blocking one node in a complex redundant network cannot produce stable intervention. — NAD Decline, Salvage Pathway Failure, and Systems-Based Restoration
- Nuchido applied systems pharmacology to aging after biogerontologist Aubrey de Grey identified aging as the most biologically complex phenomenon under study. — NAD Decline, Salvage Pathway Failure, and Systems-Based Restoration
- Conventional pharmaceutical development using a single-target model achieves a hit rate below 0.01% and requires 10–15 years from discovery to market. — NAD Decline, Salvage Pathway Failure, and Systems-Based Restoration
- Pharmaceutical companies systematically exclude natural molecules from development pipelines because they cannot be patented, regardless of efficacy data. — NAD Decline, Salvage Pathway Failure, and Systems-Based Restoration
- Systems pharmacology, developed around 2015, maps entire biological networks simultaneously rather than isolating a single target. — NAD Decline, Salvage Pathway Failure, and Systems-Based Restoration